BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

October 13, 2023 | News

HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192

HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...

October 13, 2023 | News

CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region

"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...

October 11, 2023 | News

GC Biopharma Signs Power Purchase Agreement with SK E&S

PPA is an electricity trading contract signed directly between a power generator and a customer company. Under this agreement, the company can purchase and...

October 11, 2023 | News

FDA Grants Orphan Drug Status to GC Biopharma's Thrombocytopenic Purpura Drug in South Korea

When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and exemptions from PDUFA user fees Initial Pedi...

October 06, 2023 | News

LOTTE BIOLOGICS Acquires Land in Songdo with Incheon Free Economic Zone Authority

Construction of a Bio Plant with a total production capacity of 360 kL at Songdo's Block KI20, Zone 11 by 2030 Aims to secure capabilities of an interna...

October 05, 2023 | News

Chime Biologics Partners with Korea Kings Pharm for Biosimilar Launch

Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...

September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

September 25, 2023 | News

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

Bayer Pharmaceuticals Division in Asia/Pacific announced in conjunction with World Contraception Day, the inception of its 'Bayer For Her' region...

September 25, 2023 | News

Kai Health’s Embryo Assessment AI Achieves European Medical Device Certification

Kai Health's innovative solution utilizes artificial intelligence to objectively analyze embryo images, providing predictions of embryo viability. This bre...

September 22, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized a...

September 20, 2023 | News

South Korea's ST Pharm Marks Milestone with Oligonucleotide Facility Ceremony

To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...

September 19, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Stay Connected